Want to see MKKGY full AI Analyst Report?
Merck KGaA Sponsored ADR (MKKGY) Ratios
Merck KGaA Sponsored ADR Ratios
MKKGY's free cash flow for Q2 2026 was $355.54M. For the 2026 fiscal year, MKKGY's free cash flow was decreased by $-262.46M and operating cash flow was $618.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.46 | 1.19 | 1.42 | 1.28 | 1.05 |
| Quick Ratio | 0.96 | 0.79 | 0.89 | 0.80 | 0.68 |
| Cash Ratio | 0.26 | 0.19 | 0.23 | 0.15 | 0.14 |
| Solvency Ratio | 0.18 | 0.23 | 0.22 | 0.23 | 0.20 |
| Operating Cash Flow Ratio | 0.42 | 0.41 | 0.43 | 0.45 | 0.44 |
| Short-Term Operating Cash Flow Coverage | 3.44 | 1.46 | 7.52 | 3.86 | 1.91 |
| Net Current Asset Value | $ -10.21B | $ -8.13B | $ -9.35B | $ -10.32B | $ -12.96B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.20 | 0.20 | 0.21 | 0.24 |
| Debt-to-Equity Ratio | 0.42 | 0.34 | 0.37 | 0.40 | 0.50 |
| Debt-to-Capital Ratio | 0.30 | 0.26 | 0.27 | 0.29 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.18 | 0.25 | 0.25 | 0.27 |
| Financial Leverage Ratio | 1.82 | 1.72 | 1.82 | 1.87 | 2.13 |
| Debt Service Coverage Ratio | 3.74 | 1.52 | 6.50 | 4.08 | 1.86 |
| Interest Coverage Ratio | 15.52 | 12.48 | 13.27 | 21.94 | 14.49 |
| Debt to Market Cap | 0.21 | 0.16 | 0.15 | 0.13 | 0.10 |
| Interest Debt Per Share | 5.62 | 4.86 | 4.66 | 4.88 | 5.09 |
| Net Debt to EBITDA | 1.69 | 1.36 | 1.39 | 1.43 | 1.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.35% | 59.01% | 59.03% | 61.65% | 62.66% |
| EBIT Margin | 19.26% | 18.09% | 18.13% | 20.16% | 21.17% |
| EBITDA Margin | 28.17% | 28.18% | 27.08% | 28.24% | 29.87% |
| Operating Profit Margin | 19.26% | 17.23% | 17.19% | 20.12% | 21.23% |
| Pretax Profit Margin | 15.68% | 16.71% | 16.60% | 19.28% | 19.93% |
| Net Profit Margin | 12.36% | 13.13% | 13.45% | 14.96% | 15.52% |
| Continuous Operations Profit Margin | 12.39% | 13.16% | 13.50% | 15.02% | 15.57% |
| Net Income Per EBT | 78.84% | 78.54% | 81.06% | 77.58% | 77.85% |
| EBT Per EBIT | 81.38% | 97.01% | 96.54% | 95.82% | 93.90% |
| Return on Assets (ROA) | 4.81% | 5.39% | 5.82% | 6.85% | 6.73% |
| Return on Equity (ROE) | 8.77% | 9.28% | 10.58% | 12.83% | 14.32% |
| Return on Capital Employed (ROCE) | 9.07% | 9.05% | 9.07% | 11.47% | 11.96% |
| Return on Invested Capital (ROIC) | 6.97% | 6.59% | 7.26% | 8.66% | 8.71% |
| Return on Tangible Assets | 9.46% | 10.63% | 11.72% | 14.58% | 14.73% |
| Earnings Yield | 4.72% | 4.62% | 4.61% | 4.25% | 3.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.25 | 5.19 | 5.28 | 5.38 | 5.29 |
| Payables Turnover | 6.22 | 5.77 | 4.86 | 5.34 | 4.77 |
| Inventory Turnover | 1.94 | 1.93 | 1.85 | 1.84 | 1.88 |
| Fixed Asset Turnover | 2.04 | 2.11 | 2.32 | 2.71 | 2.73 |
| Asset Turnover | 0.39 | 0.41 | 0.43 | 0.46 | 0.43 |
| Working Capital Turnover Ratio | 6.39 | 7.23 | 6.58 | 13.73 | 65.73 |
| Cash Conversion Cycle | 215.34 | 195.92 | 190.81 | 197.83 | 186.13 |
| Days of Sales Outstanding | 85.86 | 70.39 | 69.13 | 67.87 | 69.04 |
| Days of Inventory Outstanding | 188.12 | 188.75 | 196.80 | 198.27 | 193.65 |
| Days of Payables Outstanding | 58.64 | 63.23 | 75.12 | 68.32 | 76.57 |
| Operating Cycle | 273.98 | 259.14 | 265.93 | 266.14 | 262.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.74 | 2.11 | 1.74 | 1.96 | 2.12 |
| Free Cash Flow Per Share | 1.04 | 1.10 | 0.81 | 1.13 | 1.47 |
| Dividend Paid and CapEx Coverage Ratio | 1.50 | 1.86 | 1.19 | 1.54 | 2.13 |
| Capital Expenditure Coverage Ratio | 2.48 | 2.10 | 1.87 | 2.36 | 3.25 |
| Operating Cash Flow Coverage Ratio | 0.32 | 0.45 | 0.38 | 0.41 | 0.43 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.22 | 0.18 | 0.19 | 0.23 |
| Free Cash Flow Yield | 4.25% | 4.00% | 2.88% | 3.13% | 3.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.26 | 21.60 | 21.68 | 23.55 | 32.60 |
| Price-to-Sales (P/S) Ratio | 2.62 | 2.84 | 2.92 | 3.52 | 5.06 |
| Price-to-Book (P/B) Ratio | 1.86 | 2.01 | 2.30 | 3.02 | 4.67 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.53 | 25.02 | 34.77 | 31.93 | 31.17 |
| Price-to-Operating Cash Flow Ratio | 14.05 | 13.11 | 16.18 | 18.39 | 21.58 |
| Price-to-Earnings Growth (PEG) Ratio | -2.06 | -15.58 | -1.43 | 2.67 | 0.61 |
| Enterprise Value Multiple | 10.98 | 11.44 | 12.16 | 13.91 | 18.51 |
| Enterprise Value | 62.70B | 68.23B | 69.12B | 87.32B | 108.86B |
| EV to EBITDA | 10.98 | 11.44 | 12.16 | 13.91 | 18.51 |
| EV to Sales | 3.09 | 3.22 | 3.29 | 3.93 | 5.53 |
| EV to Free Cash Flow | 27.80 | 28.40 | 39.25 | 35.60 | 34.07 |
| EV to Operating Cash Flow | 16.60 | 14.88 | 18.27 | 20.50 | 23.58 |
| Tangible Book Value Per Share | 1.41 | 2.09 | 1.08 | 0.13 | -1.47 |
| Shareholders’ Equity Per Share | 13.15 | 13.76 | 12.26 | 11.93 | 9.82 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.21 | 0.19 | 0.22 | 0.22 |
| Revenue Per Share | 9.32 | 9.73 | 9.65 | 10.23 | 9.06 |
| Net Income Per Share | 1.15 | 1.28 | 1.30 | 1.53 | 1.41 |
| Tax Burden | 0.79 | 0.79 | 0.81 | 0.78 | 0.78 |
| Interest Burden | 0.81 | 0.92 | 0.92 | 0.96 | 0.94 |
| Research & Development to Revenue | 0.11 | 0.11 | 0.12 | 0.11 | 0.12 |
| SG&A to Revenue | 0.27 | 0.25 | 0.07 | 0.06 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Income Quality | 1.51 | 1.65 | 1.34 | 1.28 | 1.51 |
Currency in EUR
